Related Experiment Video
Updated: Aug 28, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Selecting optimum antihypertensive therapy: indications for choosing a calcium channel blocker
1Committee on Clinical Pharmacology, University of Chicago, Illinois 60637.
Insights
Selecting the best antihypertensive medication involves considering patient demographics, lifestyle, and coexisting conditions. Optimal therapy ensures 24-hour blood pressure control, improving patient compliance and outcomes.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Internal Medicine
Background:
- Individualized antihypertensive therapy requires careful consideration of numerous patient-specific factors.
- Demographic characteristics, circadian blood pressure patterns, and coexisting conditions influence treatment response.
- Potential drug interactions and patient lifestyle factors are critical in selecting appropriate antihypertensive agents.
Purpose of the Study:
- To review the key factors influencing the selection of optimal antihypertensive agents for individual patients.
- To highlight the importance of considering demographic, clinical, and lifestyle variables in hypertension management.
- To emphasize the need for antihypertensive therapies that ensure 24-hour blood pressure control and promote patient compliance.
Main Methods:
- Review of current literature and clinical guidelines on hypertension management.
- Analysis of factors affecting antihypertensive drug efficacy and patient adherence.
- Discussion of the role of different antihypertensive drug classes, including calcium channel blockers.
Main Results:
- Patient age, gender, race, and circadian blood pressure patterns impact antihypertensive treatment outcomes.
- Concomitant medical conditions and potential drug interactions necessitate thorough patient evaluation.
- Lifestyle, economic status, and dosing frequency significantly influence the choice and effectiveness of antihypertensive medications.
Conclusions:
- Optimal antihypertensive therapy is tailored to the individual patient, considering a wide range of factors.
- Calcium channel blockers offer versatility across age groups and are beneficial for specific concurrent conditions.
- Achieving 24-hour blood pressure control through appropriate agent selection is crucial for managing hypertension effectively and improving patient compliance.
Abstract:
In choosing the optimum antihypertensive agent for an individual patient, various factors should be considered. Demographic characteristics (e.g., age, gender, race) and the circadian pattern of blood pressure elevation may influence the response to therapy. Concomitant therapy for coexisting medical disorders must be evaluated for possible drug interactions. Calcium channel blockers, which can be used in any age group, may be particularly useful in hypertensive patients with certain concurrent conditions (e.g., coronary artery disease, migraine, or gastrointestinal motility disorders). Life-style, including occupation and leisure-time activities, may contraindicate the use of certain drugs in a particular patient. It also may be necessary to consider the economic status of the patient, particularly in the elderly, who often have limited disposable income. Since to a great extent successful therapeutic management of hypertension depends on patient compliance, reduced frequency of dosing (i.e., once or twice daily) is desirable. The clustering of morbid events in the hours immediately following awakening highlights the need for therapy that provides 24-hour control, thereby ensuring adequate pharmacodynamic effects during that crucial period. The challenge is to select the most appropriate first-line agent (diuretic, beta blocker, calcium channel blocker, or angiotensin-converting enzyme inhibitor) for a particular patient.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications

